Blockchain drug‑discovery contest
A decentralized, 24/7 global competition launched to speed drug discovery by using blockchain validators/miners and on‑chain scoring — organizers say roughly 50 molecules from the contest are now advancing to lab testing. The effort is pitched as a way to unclog Big Pharma pipelines by crowd‑sourcing candidate triage on‑chain. (x.com)
Metanova Labs deployed its NOVA subnet as Bittensor Subnet 68 with a public rollout reported on March 25, 2026. (kucoin.com) The project’s public GitHub and whitepapers document a validator/miner architecture and an on‑chain scheduler that runs adversarial, iterative screening cycles using a model family referred to as PSICHIC/“Psychic.” (github.com) Organizers describe a combinatorial‑reaction pipeline that expanded their virtual screening library to roughly 65 billion candidate molecules from earlier billion‑scale datasets. (cryptobriefing.com) Metanova has announced a commercial lab collaboration with Shanghai‑based Yalotain to synthesize and perform wet‑lab validation on top subnet hits, providing an off‑chain path for promising candidates to be experimentally tested. (techtwitter.com) CEO Micaela Bazo is publicly named on the project site, and company materials claim prior in‑network screening of about 4.8 million molecules across roughly 7,000 protein targets. (metanova-labs.ai) The NOVA GitHub shows active development—hundreds of commits and configuration files for molecule validation and scoring—indicating the protocol’s scoring, validator logic and hit‑picking tooling are being iterated in public repositories. (github.com)
